In 2020, we are celebrating the 100 most influential people in ophthalmology. Nominations are now closed and we will be announcing The Ophthalmologist Power List very soon.
Three diabetic eye disease gurus discuss prevention, detection, diagnosis, and treatment – and explain why it’s important to consider the future
AI image interpretation will not solve the diabetic retinopathy epidemic
Diabetes prevalence is set to grow by 48 percent over the next 25 years – so where does that leave ophthalmologists?
What does the future hold for the management – and treatment – of diabetic eye disease?
The winners of the ICO-Allergan Advanced Research Fellowship… in conversation.
Could an FDA-approved asthma medication offer a therapeutic pathway for diabetic retinopathy?
Send me the latest from The Ophthalmologist.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.